NASDAQ : CELZ
Creative Medical Technology Holdings, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 0.655 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 4.32M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Creative Medical Technology Holdings, Inc. (CELZ) reported revenue of 3.00K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 3.00K | 6.00K | 11.00K | 9.00K | 88.60K | 87.75K |
| Cost of Revenue | 994.00 | 2.19K | 4.40K | 3.60K | 28.49K | 47.95K |
| Gross Profit | 2.01K | 3.81K | 6.60K | 5.40K | 60.11K | 39.80K |
| Selling, General & Admin | 4.11M | 3.76M | 3.24M | 3.56M | 3.94M | 2.96M |
| Research & Development | 2.02M | 2.26M | 2.40M | 1.97M | 6.27M | 109.18K |
| Amortization of Goodwill & Intangibles | 113.78K | 123.33K | 110.45K | 94.58K | 92.08K | 92.08K |
| Operating Expenses | 6.24M | 6.15M | 5.75M | 5.63M | 10.30M | 3.17M |
| Operating Income | -6.24M | -6.14M | -5.74M | -5.62M | -10.24M | -3.13M |
| Interest Expense | -4.28M | |||||
| Interest & Investment Income | 201.56K | 147.81K | 250.38K | 333.56K | 100.33K | |
| Other Non Operating Income (Expenses) | 26.03M | |||||
| EBT Excluding Unusual Items | -6.04M | -6.00M | -5.49M | -5.29M | -10.14M | 18.63M |
| Other Unusual Items | 585.60K | |||||
| Pretax Income | -6.04M | -6.00M | -5.49M | -5.29M | -10.14M | 19.21M |
| Net Income | -6.04M | -6.00M | -5.49M | -5.29M | -10.14M | 19.21M |
| Net Income to Common | -6.04M | -6.00M | -5.49M | -5.29M | -10.14M | 19.21M |
| Shares Outstanding (Basic) | 3.09M | 2.38M | 1.48M | 1.41M | 1.09M | 260.51K |
| Shares Outstanding (Diluted) | 3.09M | 2.38M | 1.48M | 1.41M | 1.09M | 324.86K |
| EPS (Basic) | -1.95 | -2.52 | -3.71 | -3.76 | -9.28 | 73.75 |
| EPS (Diluted) | -1.95 | -2.52 | -3.71 | -3.76 | -9.28 | 56.10 |
| Gross Margin | 66.87% | 63.43% | 60.00% | 60.00% | 67.84% | 45.36% |
| Operating Margin | -208,004.40% | -102,380.23% | -52,216.92% | -62,445.91% | -11,562.50% | -3,562.17% |
| Profit Margin | -201,355.37% | -99,916.80% | -49,940.74% | -58,739.71% | -11,449.26% | 21,892.76% |
| EBITDA | -6.13M | -6.02M | -5.63M | -5.53M | -10.15M | -3.03M |
| D&A For EBITDA | 113.78K | 123.33K | 110.45K | 94.58K | 92.08K | 92.08K |
| EBIT | -6.24M | -6.14M | -5.74M | -5.62M | -10.24M | -3.13M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 8.71M | 7.21M | 5.94M | 3.47M | 8.32M | 10.72M |
| Short-Term Investments | 125.00K | 6.52M | 10.08M | |||
| Cash & Short-Term Investments | 8.84M | 7.21M | 5.94M | 9.99M | 18.40M | 10.72M |
| Accounts Receivable | 2.48K | |||||
| Receivables | 109.34K | 52.08K | 2.48K | |||
| Inventory | 2.19K | 6.59K | 10.19K | 10.87K | ||
| Prepaid Expenses | 70.46K | 138.80K | 192.71K | 277.25K | 338.12K | |
| Total Current Assets | 9.02M | 7.40M | 6.14M | 10.27M | 18.75M | 10.74M |
| Other Intangible Assets | 355.46K | 407.23K | 530.56K | 441.01K | 435.60K | 527.68K |
| Other Long-Term Assets | 3.28K | 3.28K | 3.28K | 3.28K | 3.28K | 3.28K |
| Total Assets | 9.38M | 7.81M | 6.67M | 10.72M | 19.19M | 11.27M |
| Accounts Payable | 684.40K | 270.69K | 273.53K | 317.28K | 3.27M | 761.86K |
| Accrued Expenses | 39.92K | 39.92K | 39.92K | 274.38K | ||
| Short-Term Debt | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K |
| Total Current Liabilities | 698.60K | 284.88K | 327.64K | 371.39K | 3.32M | 1.05M |
| Total Liabilities | 698.60K | 284.88K | 327.64K | 371.39K | 3.32M | 1.05M |
| Common Stock | 6.49K | 3.14K | 1.75K | 1.43K | 1.41K | 6.34K |
| Additional Paid-In Capital | 82.16M | 78.11M | 70.93M | 69.71M | 69.68M | 53.88M |
| Retained Earnings | -73.50M | -70.59M | -64.59M | -59.10M | -53.81M | -43.67M |
| Treasury Stock | -10.00K | -10.00K | -270.95K | |||
| Total Common Equity | 8.65M | 7.51M | 6.34M | 10.34M | 15.86M | 10.22M |
| Minority Interest | 24.09K | 10.00K | ||||
| Shareholders' Equity | 8.68M | 7.52M | 6.34M | 10.34M | 15.86M | 10.22M |
| Total Liabilities & Equity | 9.38M | 7.81M | 6.67M | 10.72M | 19.19M | 11.27M |
| Total Debt | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K | 14.19K |
| Net Cash (Debt) | 8.82M | 7.19M | 5.93M | 9.97M | 18.38M | 10.71M |
| Net Cash Per Share | 2.85 | 3.02 | 4.00 | 7.08 | 16.82 | 32.97 |
| Filing Date Shares Outstanding | 6.59M | 3.70M | 1.75M | 1.36M | 1.41M | 651.47K |
| Total Common Shares Outstanding | 6.49M | 3.70M | 1.75M | 1.37M | 1.41M | 633.89K |
| Working Capital | 8.32M | 7.11M | 5.81M | 9.90M | 15.43M | 9.69M |
| Book Value Per Share | 1.33 | 2.03 | 3.63 | 7.53 | 11.27 | 16.12 |
| Tangible Book Value | 8.30M | 7.11M | 5.81M | 9.90M | 15.43M | 9.69M |
| Tangible Book Value Per Share | 1.28 | 1.92 | 3.32 | 7.21 | 10.96 | 15.29 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -6.04M | -6.00M | -5.49M | -5.29M | -10.14M | 19.21M |
| Depreciation & Amortization | 113.78K | 123.33K | 110.45K | 94.58K | 92.08K | 92.08K |
| Other Amortization | 4.16M | |||||
| Loss (Gain) From Sale of Investments | -34.09K | |||||
| Stock-Based Compensation | 3.48K | 36.65K | 36.65K | 68.75K | 595.38K | |
| Other Operating Activities | -6.75K | -1.58K | -26.52M | |||
| Change in Accounts Receivable | 2.48K | -2.48K | ||||
| Change in Inventory | 994.00 | 2.19K | 4.40K | 3.60K | 672.00 | -10.87K |
| Change in Accounts Payable | 13.79K | -2.84K | -43.85K | -2.95M | 2.51M | 410.96K |
| Change in Other Net Operating Assets | 17.13K | 13.98K | 84.54K | 108.20K | -322.58K | -148.15K |
| Operating Cash Flow | -5.90M | -5.86M | -5.30M | -8.03M | -7.80M | -2.22M |
| Sale (Purchase) of Intangibles | -200.00K | -100.00K | ||||
| Investment in Securities | -125.00K | 6.52M | 3.55M | -10.08M | ||
| Other Investing Activities | -100.50K | -50.50K | ||||
| Investing Cash Flow | -225.50K | -50.50K | 6.32M | 3.45M | -10.08M | |
| Short-Term Debt Issued | 4.11M | |||||
| Long-Term Debt Issued | 435.04K | |||||
| Total Debt Issued | 4.55M | |||||
| Short-Term Debt Repaid | -5.47M | |||||
| Long-Term Debt Repaid | -705.40K | |||||
| Total Debt Repaid | -6.18M | |||||
| Net Debt Issued (Repaid) | -1.63M | |||||
| Issuance of Common Stock | 8.28M | 7.17M | 1.63M | 15.47M | 14.76M | |
| Repurchase of Common Stock | -10.00K | -174.96K | -270.95K | |||
| Other Financing Activities | 22.00K | 10.00K | -551.70K | |||
| Financing Cash Flow | 8.30M | 7.17M | 1.45M | -270.95K | 15.47M | 12.84M |
| Net Cash Flow | 2.17M | 1.27M | 2.47M | -4.85M | -2.40M | 10.63M |
| Levered Free Cash Flow | -3.46M | -3.75M | -3.60M | -6.37M | -4.31M | -38.48M |
| Unlevered Free Cash Flow | -3.46M | -3.75M | -3.60M | -6.37M | -4.31M | -39.96M |
| Cash Interest Paid | 9.19K | |||||
| Change in Working Capital | 31.91K | 13.34K | 45.09K | -2.84M | 2.19M | 249.47K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 4.32M | 6.85M | 4.04M | 6.37M | 5.36M | 13.98M |
| Enterprise Value | -4.51M | 1.49M | -2.21M | -5.59M | -16.61M | 14.37M |
| Last Close Price | 0.66 | 1.96 | 2.31 | 4.61 | 3.81 | 22.10 |
| PE Ratio | 0.73 | |||||
| PS Ratio | 1,439.38 | 1,141.59 | 367.17 | 707.96 | 60.55 | 159.35 |
| PB Ratio | 0.49 | 0.91 | 0.64 | 0.62 | 0.34 | 1.37 |
| P/TBV Ratio | 0.52 | 0.96 | 0.69 | 0.64 | 0.35 | 1.44 |
| EV/Sales Ratio | 248.04 | 163.74 | ||||
| Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt / Equity Ratio | -1.02 | -0.96 | -0.94 | -0.96 | -1.16 | -1.05 |
| Net Debt / EBITDA Ratio | 1.44 | 1.20 | 1.05 | 1.80 | 1.81 | 3.53 |
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
| Inventory Turnover | 1.00 | 0.43 | 2.71 | |||
| Quick Ratio | 12.65 | 25.30 | 18.13 | 26.89 | 5.54 | 10.21 |
| Current Ratio | 12.91 | 25.97 | 18.73 | 27.66 | 5.64 | 10.22 |
| Return on Equity (ROE) | -77.88% | -86.47% | -65.85% | -40.34% | -77.78% | |
| Return on Assets (ROA) | -47.32% | -53.03% | -41.30% | -23.49% | -42.05% | -32.60% |
| Return on Capital Employed (ROCE) | -71.90% | -81.60% | -90.60% | -54.30% | -64.60% | -30.60% |
| Earnings Yield | -298.22% | -87.52% | -136.01% | -82.97% | -189.10% | 137.39% |
| Buyback Yield / Dilution | -61.50% | -60.95% | -5.17% | -28.76% | -236.51% | -460.63% |